Oncogenic Ras interferes with adhesive functions of epithelial cells, but requires tumor growth factor b (TGFb) signaling to cause epithelial-mesenchymal transition (EMT) and tumor progression in model systems. To investigate the mechanisms by which Ras and TGFb pathways cooperate in EMT induction, we introduced a tamoxifen-inducible version of Raf-1 (RafER) into fully polarized, mammary epithelial cells (EpH4). EMT characterized by loss of E-cadherin expression and upregulation of invasiveness-promoting genes was induced by TGFb plus 4-hydroxytamoxifen (4HT) activation of RafER. Downregulation of E-cadherin by RafER plus TGFb was detectable in total cell lysates after 48 h and much earlier in detergent-insoluble fractions of E-cadherin. Both pathways cooperated to strongly enhance endocytosis of E-cadherin, mainly via the clathrin-dependent route. Pulse-chase experiments showed decreased E-cadherin protein stability in cells stimulated with TGFb and 4HT and increased E-cadherin half-life in the presence of monensin. Monensin and chloroquine prevented E-cadherin degradation to different extent, but only monensin effectively blocked the loss of E-cadherin from the junctional complexes. Both lysosome inhibitors caused accumulation of E-cadherin vesicles, some of which were positive for Cathepsin D and lysosome-associated membrane protein 1 (LAMP-1). In addition, TGFb and mitogen-activated protein kinase hyperactivation synergistically induced E-cadherin ubiquitination, suggesting that the cooperation of Raf and TGFb favors lysosomal degradation of E-cadherin instead of its recycling. Our data indicate that early stages of EMT involve cooperative, post-translational downregulation of E-cadherin, whereas loss of E-cadherin via transcriptional repression is a late event in EMT.
Introduction
E-cadherin is a transmembrane cell surface glycoprotein and a main component of adherens junctions in polarized epithelial cells. The extracellular domain mediates homophilic, calcium-dependent interactions required for adhesion, whereas the intracellular domain interacts with the actin cytoskeleton through a complex of anchoring proteins like b-catenin, p120 and a-catenin (Kemler, 1992) . The adhesive function of E-cadherin both requires an intact extracellular domain as well as proper interaction with b-catenin, which can be abolished by mutations in or truncation of the interacting domains or tyrosine phosphorylation of both b-catenin and E-cadherin (Gumbiner, 2000) .
E-cadherin plays critical roles in cell adhesion, development of epithelial organs and establishment/ maintenance of epithelial polarity. Progression of benign tumors to invasive metastatic cancer involves partial or complete loss of E-cadherin expression, or an impairment of its adhesive function (Christofori and Semb, 1999) . Loss of E-cadherin can occur through deletion or mutational inactivation of the E-cadherin gene or transcriptional repression of E-cadherin by transcription factors, such as Slug/Snail (Batlle et al., 2000) . Besides transcriptional control, considered as a major mechanism causing loss of E-cadherin in cancer, more recent evidence also suggests post-translational mechanisms like endocytosis (Le et al., 1999; Ivanov et al., 2004) , O-glycosylation of newly synthesized E-cadherin interfering with cell surface expression (Zhu et al., 2001) and ubiquitination/degradation of tyrosine phosphorylated E-cadherin by the E3 ubiquitin ligase Hakai (Fujita et al., 2002) . Recently, ubiquitin tagging was shown to be sufficient to deliver E-cadherin to lysosomes, which was correlated with a partial fragmentation of E-cadherin in response to Src activation in Madin-Darby canine kidney (MDCK) cells (Palacios et al., 2005) .
Epithelial-mesenchymal transition (EMT) denotes the conversion of epithelial cells into cells with mesenchymal properties, such as fibroblastoid morphology and increased migration. Gradual loss of typical epithelial markers, like E-cadherin and ZO-1, and induction of mesenchymal genes is central to EMT process (Thiery, 2002) . EMT frequently occurs during embryonic development and organ remodeling (Viebahn, 1995; Sun et al., 2000) . EMT is also increasingly recognized as a crucial process during cancer progression (e.g. from benign adenoma to metastatic carcinoma). In particular, the ability of transforming growth factor b (TGFb) to induce EMT has been correlated with a tumor-promoting role of TGFb during late-stage cancer development, contrasted by TGFb-induced cell cycle arrest and apoptosis induced in normal epithelial cells (Derynck et al., 2002; Grunert et al., 2003) . Using fully polarized mammary epithelial cells (EpH4) transformed with oncogenic Ras (Ep2Ras), we showed that a Ras-induced hyperactive extracellular signal-regulated kinase (ERK)/ mitogen-activated protein kinase (MAPK) signaling cooperating with TGFb is required to cause EMT in vitro and in vivo and tumor metastasis in nude mice (Oft et al., 1996; Janda et al., 2002a) . In contrast, Ras-induced phosphatidylinositol 3 0 -kinase signaling was required for efficient protection from TGFbinduced apoptosis as well as for rapid tumor growth (Janda et al., 2002b) . A similar cooperation between the activation of the downstream Ras effector Raf-1 and TGFb signaling is required for EMT and in vitro invasive behavior of MDCK cells (Lehmann et al., 2000) . MDCK cells, however, are less appropriate compared to the EpH4/EpRas system as they neither form in vivo-like organotypic structures in three-dimensional collagen gel cultures nor do they easily allow analysis of genetically modified cells in vivo, owing to their dog origin.
In this paper, we combine the well-characterized in vitro/in vivo cellular model EpH4/EpRas with inducible activation of the ERK pathway through RafER, a fusion protein of Raf-1 and the hormonebinding domain of the estrogen receptor (ER), which can be functionally activated by the addition of an ER ligand, . In this work, we addressed how MAPK pathway and TGFb signaling cross-talk to regulate E-cadherin levels at the onset of EMT. We found that in the initial phases of EMT, E-cadherin is downregulated at the posttranslational level and not at the transcriptional level in contrast to the majority of gene targets regulated by TGFb and Raf cooperation. This is owing to enhanced endocytosis and lysosomal degradation induced by synergistic activation of both pathways. Our data show that in this model system of carcinoma progression, the post-translational downregulation via lysosomes precedes the transcriptional repression of E-cadherin and therefore may indicate a novel direction for therapeutic intervention against metastasis.
Results

Dose-dependent effects of Raf activation on cell proliferation and epithelial polarity
In several epithelial cell models, cooperation of the Raf/ ERK/MAPK pathway and TGFb signaling is required for induction and maintenance of EMT in vitro and a metastatic phenotype in vivo (Lehmann et al., 2000; Janda et al., 2002a) . To investigate the mechanism of how Raf and TGFb signaling cooperate in these processes, we generated EpH4 cells stably expressing an 4HT-inducible RafER construct (EGFP-DRaf1-hbER(YY)) (Woods et al., 1997) . EpH4 cells were infected with retroviruses encoding this inducible version of Raf. Drug selection and fluorescence-activated cell sorting (FACS) for green fluorescence protein (GFP)-positive cells yielded two clones (named R3, R5) stably expressing RafER construct upon its activation ( Figure 1a , middle panel). To analyse RafERinduced MAPK activation in response to 4HT, confluent cells were starved for 48 h and then treated with different concentrations of 4HT. This caused strong and dose-dependent ERK phosphorylation ( Figure 1a , upper panel), thus confirming the possibility to control strictly the level of hyperactivation of ERK/ MAPK pathway, that is, phosphorylation beyond the level present in non-stimulated cells in identical culture conditions. RafER activation also affected cell proliferation in a dose-dependent manner as shown by effects on DNA synthesis (Figure 1b) , as seen earlier in RafER fibroblasts (Woods et al., 1997) . Moderate RafER activation by 0.05-0.1 mM 4HT slightly stimulated or did not affect cell proliferation, whereas higher 4HT concentrations (>0.5 mM) strongly inhibited proliferation. 4HT had no effect on proliferation and on ERK phosphorylation in EpH4 cells expressing the hormone binding domain of ER only (hb-EpH4) (Figure 1b and Supplementary Information Figure 1 , respectively). In addition, the activation of MAPK pathway in RafER clones caused a dose-dependent loss of polarity in the epithelial layer verified by redistribution of E-cadherin and ZO-1 as shown in Figure 1c . The hyperactivation of ERK kinases observed in EpH4 cells transformed with Ras (EpRas) (Figure 1a , first lane) was comparable to what could be induced by 0.1 mM 4HT. Such a stimulation of Raf mildly altered epithelial polarity (Figure 1c ), but failed to affect proliferation. This concentration was used in later experiments to address the early effects of ERK/MAPK pathway activation and its cooperation with TGFb signaling during EMT induction.
TGFb and activation of RafER synergize in the induction of EMT In the first series of experiments, we addressed if the inducible Raf/MAPK hyperactivation can cooperate with TGFb in the induction of EMT. Cells of the previously characterized RafER-EpH4 clone R5 were cultivated on plastic and stimulated or not stimulated with 0.1 mM 4HT. These treatments were performed in the presence or absence of TGFb. After 48 h, 4HT applied alone caused the partial loss of polarity (Figure 2b ), whereas stimulation with TGFb for the same time resulted in flattened, more irregular morphology (Figure 2c ). However, when treated with both TGFb and 4HT, the cells not only lost epithelial Endocytosis and lysosomal degradation of E-cadherin E Janda et al polarity, but showed a dramatic elongation, accompanied by a tendency to grow in multilayers ( Figure 2d ). To confirm that these morphological changes corresponded to EMT, we performed epithelial and mesenchymal marker analysis. Cells were seeded on porous supports to allow polarization as monolayers (3 days) and treated with 0.1 mM 4HT and/or 2.5 ng/ml TGFb for 48 h or 6 days, fixed and analysed for the expression of E-cadherin and Vimentin by immunostaining. After 48 h and 6 days of treatment, 4HT alone caused diffused membrane staining of E-cadherin (Figure 2f and j). TGFb alone caused changes in the cell shape (more irregular, elongated) and a significant delocalization of E-cadherin from the cell membrane to the cytoplasm, but not its downregulation and only minimal upregulation of Vimentin (Figure 2g and k) . This effect was, however, cell density dependent (weaker in very dense cell clusters) and especially dependent on the 'maturity' of the epithelial monolayer. In fact, TGFb induced no morphological response in fully mature epithelial layer, cultured for more than 5 days on filters (data not shown). In contrast, TGFb and 4HT added together caused progressive changes in the cells response independent of cell density, that is, a strong delocalization and partial downregulation of E-cadherin within 48 h and a strong downregulation of E-cadherin and a significant upregulation of Vimentin after 6 days ( Figure 2h and l) .
In conclusion, RafER cells subjected to long-term treatment TGFb alone undergo 'scattering', a fibroblastoid, migratory phenotype in which E-cadherin expression is maintained and no upregulation of mesenchymal markers occurs. In contrast, TGFb plus 4HT induced a fibroblastoid phenotype after 48 h and clear markers of EMT after 6 days.
Downregulation of E-cadherin at the onset of EMT is not transcriptional
The strong, EMT-like response of the EpH4-RafER cells to combined activation of RafER and TGFbR signaling raised the question whether this synergistic action of the two pathways could also be observed at the level of gene expression. For this reason, RafER EpH4 ) were seeded onto filters, grown to confluency and treated with different concentrations of 4HT as indicated. After 48 h, the cells were fixed and stained with antibodies to ZO-1 (green channel) and E-cadherin (red channel). Representative fields were analysed by confocal laser scanning microscopy. Lateral images shown at the bottom (XZ) and left border of panels (YZ) represent vertical sections through three-dimensional image stacks (40-50 XY images, section step 0.2 mM). Bar, 20 mM. Arrows indicate the apical side of the epithelial layer section.
Endocytosis and lysosomal degradation of E-cadherin E Janda et al cells were analysed for mRNA levels of markers for EMT or target genes of TGFb signaling. Northern blot analysis was performed on the RNA samples from cells grown on filters and treated for 6, 48 h or 5 days before the lysis (Figure 3a) . Untreated cells were processed as controls. In contrast to what was expected both after 6 and 48 h, E-cadherin was not significantly reduced in the double-treated cells, similarly to the cells treated with 4HT or TGFb alone. A clear reduction in E-cadherin mRNA appeared only 5 days after EMT induction in double-treated cells. On the contrary, the analysis of mRNA for plasminogen activator inhibitor 1 (PAI-1), a typical target of TGFb and a marker of invasiveness (Harbeck et al., 1999) , revealed that both pathways synergy to induce several fold higher levels of PAI-1 than with TGFb alone. The extracellular matrix (ECM) protein Tenascin, another target gene of TGFb, was induced strongly by TGFb and weakly by RafER activation, whereas stimulation of both pathways together had an additive effect. In conclusion, in contrast to many proteins related to invasive features of epithelial cells like PAI-1 and Tenascin that are transcriptionally regulated, unexpectedly E-cadherin does not seem to be repressed at early stages of EMT.
To determine the time point at which a reduction of E-cadherin levels could first be detected, we performed Western blot analysis of total protein lysates (in sodium dodecyl sulfate (SDS) lysis buffer) of cells treated at different time points before lysis. As shown in Figure 3b , treatment with 4HT and TGFb but not either agent alone induced B50% reduction in E-cadherin after 48 h (Figure 3b ). The actual extent of E-cadherin reduction was, however, cell density dependent (data not shown). This downregulation progressed with time, together with the increasingly invasive-like features of doubletreated cells, leading to a five-fold downregulation of E-cadherin after 5 days of treatment (Figure 3b ) only in double-treated cells. The analysis of RNA in the same experiment confirmed that E-cadherin message was found reduced only in samples from day 5 (data not shown).
Therefore, the earliest time point at which E-cadherin reduction is detected in total SDS lysates is 48 h. However, reduction of E-cadherin levels in the detergentinsoluble fraction of cytoskeleton (CSK) buffer (0.1% Triton-Tx), likely to contain the E-cadherin pool strongly stabilized in junctional complexes (Zhu et al., 2001) , was already detectable after 24 h (Figure 3c ).
So far, our results suggest that loss of E-cadherin protein clearly precedes transcriptional downregulation of E-cadherin message by >2-3 days. As this finding has never been reported previously, we were interested if this is an unusual feature of RafER-EpH4 cells or a common feature of any EMT process. We verified it in other two well-characterized cell systems: EpRas requiring only TGFb to undergo EMT (Oft et al., 1996) and (red) . Narrow panels at the bottom and left border of panels: Z sections through stained cell layers generated from stacks of B40 XY images. Arrows indicate the apical side of the epithelial layer. Bar, 50 mm. (i-l) RafER cells (clone R5) were analysed 6 days after treatment with TGFb (2.5 ng/ml), 4HT (0.1 mM) or both. Immunofluorescence analysis after staining for E-cadherin (green) and vimentin (red) is shown. Nuclei (DNA) were stained with DAPI (blue). Bar on images h and l, 20 mm.
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FosER cells, in which an estradiol-activated c-FosER fusion protein induces EMT in the absence of other signals (Reichmann et al., 1992) . Cells were seeded on filters, subjected to the respective treatments for different time periods and lysates processed for parallel mRNA and protein analysis. As shown in Figure 4b , in both systems, protein levels were detectably reduced 48 h after treatment, whereas mRNA levels were reduced only after 5 days of treatment ( Figure 4a ). In conclusion, early phases of EMT are characterized by E-cadherin protein degradation owing to post-translational mechanisms, whereas transcriptional downregulation is a late process.
TGFb plus Raf activation enhance E-cadherin endocytosis
As shown above, E-cadherin reduction during EMT is slow, which renders classical proteasomal degradation unlikely as a direct mechanism for E-cadherin turnover. (a) RafER and TGFb upregulate mRNA specific for EMT markers and/or TGFb targets in an additive or synergistic manner, but do not strongly affect E-cadherin mRNA levels. Total RNA was prepared from cells (RafER clone R5) grown on Transwell filters and lysed 6 h, 48 h or 5 days (5d) after stimulation with TGFb (2.5 ng/ml), 4HT (0.1 mM) or both (4HT plus TGFb). Untreated RafER cells (Con) were processed in parallel. Cells were 50% confluent at the start of the treatment (see Materials and methods). Two Northern blots containing identical total RNA samples were run in parallel and analysed with cDNA probes for mouse E-cadherin and mouse PAI-1 and human Tenascin. 18S mRNA levels are shown as the loading control. (b) Time course of E-cadherin protein downregulation during EMT induction in RafER cells treated with the same agents as in panel a for up to 5 days and analysed by Western blot using total cell lysates (SDS lysis buffer). Cells were seeded 50% confluent at the start of the treatment. Arbitrary units of integrated optical density (normalized to the loading control band) are reported below each lane. Integrated optical density was quantified by Scion Image software. 'Con' refers to untreated RafER cells. This experiment was performed several times and yielded similar results. (c). Downregulation in the insoluble fraction of E-cadherin is detectable between 12 and 24 h. Cell lysates were prepared in a CSK buffer containing 0.1% Triton, separated into detergent-soluble (intracellular) and -insoluble fractions (cytoskeleton boundmembrane E-cadherin). Corresponding aliquots of soluble and insoluble fractions were loaded on the same gel and analysed for E-cadherin protein by Western blot (for details see Materials and methods). In this fractionation method, actin partitions both to soluble and insoluble fractions (second panel), whereas all a-tubulin is found only in the soluble fractions (third panel). Note: TGFb plus 4HT-induced downregulation of E-cadherin in insoluble material after 24 h.
Endocytosis and lysosomal degradation of E-cadherin E Janda et al Indeed, it was not possible to detect a characteristic laddering of E-cadherin indicating the accumulation of its ubiquitinated forms in samples treated with TGFb and 4HT and proteasome inhibitors like PSI (see Supplementary Information Figure 2 ). Most cell membrane proteins are regulated by endocytosis and lysosomal degradation. Endocytosis and recycling of E-cadherin occurs even in fully polarized epithelial layer, but is strongly increased upon loss of E-cadherin-mediated cell/cell adhesion induced by Ca 2 þ chelating agents or receptor tyrosine kinase ligands like human growth factor (Le et al., 1999) . Therefore, we analysed, both by Western blot and confocal microscopy, whether or not TGFb, 4HT or both augmented E-cadherin internalization in RafEREpH4 cells. We used a method of lysate fractionation between soluble and insoluble pools of E-cadherin in a buffer containing 0.1% Triton-X100 (modified CSK buffer). This buffer allows one to distinguish between intracellular and cytoskeleton-bound membrane pools of E-cadherin. Confluent monolayers were treated with the above agents and lysed 30 h later. Under these conditions, the majority of total E-cadherin was found in the soluble pool, with very low levels persisting in the insoluble, membrane-bound pool ( Figure 5a , lanes 4 and 8). In contrast, untreated control cells showed the expected, opposite distribution, with very low soluble and very high membrane-bound E-cadherin levels ( Figure 5a , compare lanes 1 and 5). In these experimental conditions, 4HT induced stronger, whereas TGFb a weaker E-cadherin redistribution (compare lanes 3 and 2). As the cytoplasmic pool of E-cadherin analysed in Figure 5a contains both newly synthesized and internalized pool of E-cadherin, we verified how much E-cadherin is contained in the biosynthetic pathway, by blocking the protein synthesis with 3 h pretreatment with cycloheximide. The protein synthesis block reduced only marginally the soluble fraction of E-cadherin (Supplementary Information Figure 3a ). It suggests that induction of EMT by 4HT and TGFb causes internalization of E-cadherin.
To determine if this cytoplasmic pool of E-cadherin is generated through endocytosis, we first cultured controland 4HT plus TGFb-treated cells seeded on Transwell filters at 181C for 3 h, which blocks membrane protein recycling, that is, re-integration of internalized proteins to the cell surface (Le et al., 1999) . E-cadherin accumulated in vesicular structures in control cells, but the vesicular staining was much more pronounced in cells treated with 4HT and TGFb for 22 h before the temperature block (Figure 5b , compare first panels). Instead, cells treated with single factors showed intermediate intensity of granular E-cadherin accumulation (data not shown). To check whether the granular staining of E-cadherin corresponded to vesicles of the endocytic pathway, we performed immunofluorescence analysis for colocalization of endocytosis markers and E-cadherin. We could find only a small fraction of intracellular E-cadherin that was Rab5 or clathrin positive in control cells (Figure 5b , first row and data not shown). The analysis of spots induced by 181C temperature block in 4HT and TGFb-treated cells revealed that many of E-cadherin spots were positive in early endosome markers like clathrin or Rab5 (Figure 5c , second and third row). E-cadherin was also reported to be internalized by caveolae (Akhtar and Hotchin, 2001 ). In addition, a caveolin-dependent endocytosis of tight junction proteins takes place during depolarization of epithelial monolayers by pharmacological means (Shen and Turner, 2005) . Therefore, we addressed the possibility that in our system, some E-cadherin enters the cytoplasm by caveole-dependent mechanism. However, we could find very few caveolin-E-cadherin double-positive vesicles in RafER cells 24 h after EMT induction, although E-cadherin well colocalized with caveolin in the cell membrane (Figure 5c ).
To corroborate the colocalization studies with biochemical data, we tried to interfere with E-cadherin internalization by agents blocking clathrin-dependent endocytosis or caveole formation. Assuming that any possible endocytosis block might be detected by changes in soluble and insoluble fractions of E-cadherin, we used the fractionation method to follow E-cadherin redistribution in the presence of endocytosis inhibitors. Hypertonic buffer is often employed as means to inhibit the clathrin-dependent endocytosis (Wu et al., 2001) . We incubated the RafER-EpH4 epithelial monolayers and cells undergoing EMT in Hank's balanced salt solution (HBSS) buffer containing 0.4 M sucrose. Hypertonic conditions caused a loss of insoluble E-cadherin and increase in soluble E-cadherin in control monolayers (Figure 5d ). This unexpected result might be owing to unspecific depolarization of EpH4 monolayers caused by hyperosmolarity, as reported in polarized MDCK cells (Shen and Turner, 2005) . On the contrary in EMT cells that are by definition well depolarized, we observed an increase in membrane-bound, insoluble E-cadherin Figure 4 Time course of downregulation of E-cadherin mRNA and protein levels during EMT induction in EpRas and FosER cells. Cells were seeded onto Transwell filters and EMT was induced at B80% confluency by TGFb (5 ng/ml) or b-estradiol (1 mM) for the time periods indicated. Total RNA (a) and total SDS lysates (b) were obtained at the same time from parallel cultures and later analysed for E-cadherin mRNA (a) and protein (b). PAI-1 mRNA levels were analysed as a control for EMT induction. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ERK2 levels are shown as loading controls for RNA and protein, respectively. Note that protein levels of E-cadherin decrease earlier than mRNA levels.
Endocytosis and lysosomal degradation of E-cadherin E Janda et al Colocalization of E-cadherin and the early endosome markers clathrin and Rab5 in vesicles induced by 'temperature block'. RafEREpH4 cells were seeded onto Transwell filters and cultured for 3 days before the addition of TGFb and 4HT for 45 h at 371C and 3 h at 181C. Next, cells were fixed in 4% PFA and stained as described in Materials and methods section. Bar, 10 mM. (c) E-cadherin and caveolin double-staining shows no colocalization in vesicles induced by block of recycling at 181C (3 h). RafER monolayers were treated with TGFb plus 4HT 22 h before the incubation at 181C. Transwell filters were processed as in (c). Bar, 10 mM. (d) Analysis of E-cadherin redistribution in hypertonic conditions (0.4 M sucrose) that interfere with clathrin-dependent endocytosis. RafER cells cultured on filters for 3 days were induced with TGFb and 4HT for 48 h. Next, the cells were equilibrated in HBSS-HEPES (4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid) (30 min) followed by the addition of HBSS-HEPES70.4 M sucrose at 181C for 3 h. After this, time cells were lysed and lysates were processed as in (a). Note opposed effect of sucrose on polarized (con) and EMT cells (plus TGFb and 4HT). (e) Effect of chlorpromazine on E-cadherin redistribution between soluble and insoluble fractions in EMT RafER cells. Cells were stimulated with factors inducing EMT (TGFb and 4HT) for 3 days before the addition of chlorpromazine (25 mg/ml) for 5 h. Cells were lysed in CSK buffer 0.1% Triton-Tx and processed as in (a). Note the increase in the insoluble fraction and decrease in the soluble fraction of E-cadherin, suggesting a block in the migration of E-cadherin from membrane to the cytosol. (f) Analysis of E-cadherin fractions in the presence of nystatin -a caveole formation-blocking agent. Cells polarized for 4 days and then treated or untreated for additional 48 h to induce EMT were subsequently treated with nystatin (50 mg/ml). After 5 h, treatment cells were lysed and processed as in (a). (g) Immunofluorescence analysis of E-cadherin in the cells treated with chlorpromazine or nystatin. RafER cells growing on Transwell filters were stimulated with TGFb and 4HT for 3 days to induce EMT and then they were treated with chlorpromazine (25 mg/ml) or nystatin (25 mg/ml) and incubated at 181C to cause accumulation of endocytic vesicles for 4 h. Rat anti-E-cadherin (Zymed) was used for immunofluorescence staining. Representative confocal sections are shown. Bar, 10 mm.
Endocytosis and lysosomal degradation of E-cadherin E Janda et al (compare lanes 6 and 8, Figure 5d ) and a detectable decrease in the soluble fraction after treatment with 0.4 M sucrose (lanes 2 and 4, Figure 5d ). To provide further evidence, we incubated the control polarized cells and well-induced RafER cells (4 days) in the presence of chlorpromazine. Chlorpromazine is a cationic amphiphilic drug which prevents the recycling of clathrin and thus prevents endocytosis by clathrindependent mechanisms (Wang et al., 1993) . Similarly to hypertonic buffer, chlorpromazine caused increase in soluble fraction of E-cadherin in control monolayers, but it blocked the migration of E-cadherin from membrane-insoluble fraction into soluble fraction in cells undergoing EMT (Figure 5e ). This may suggest that in cells stimulated with TGFb plus 4HT, E-cadherin internalization is mediated mainly by clathrin-coated vesicles. To investigate the role of caveole in E-cadherin internalization, we treated cells with nystatin -a sterol binding agent able to remove membrane cholesterol and thereby prevent the maintenance of caveolae and caveole pit formation (Lisanti et al., 1993) . Nystatin did not prevent the migration of E-cadherin from the plasma membrane fraction to the soluble fraction (Figure 5f ). To provide evidence that observed changes in E-cadherin solubility are related to a specific block in E-cadherin internalization, we performed the analysis of E-cadherin immuofluorescence in EMT cells treated with drugs used in experiments described in Figure 5e and f. Cells undergoing EMT were incubated at 181C for 4 h and treated or untreated with chlorpromazine or nystatin. Chlorpromazine slightly reduced the number of clathrin-positive vesicles and it caused more intense membrane E-cadherin staining and more regular morphology in cells treated with this drug (Figure 5g ). These data were in line with findings in Figure 5e . Similarly, the overall intensity of intracellular and membrane E-cadherin in cells treated with nystatin was comparable to control cells, as expected in light of fractionation data. However, we found fewer vesicles and rather diffuse intracellular E-cadherin upon nystatin treatment (Figure 5g ). This suggests that intact caveole may also be necessary for proper internalization of E-cadherin. In conclusion, these data suggest that in depolarized epithelial cells undergoing EMT, the endocytosis of E-cadherin involves mainly the clathrin-dependent pathway, but cannot exclude a contribution of caveolindependent pathway.
EMT enhances degradation of E-cadherin via the lysosome Next, we investigated if the cytosolic pool of E-cadherin is affected by the block of lysosome function. We used three different drugs to inhibit the lysosome function: monensin, ammonium chloride (NH 4 Cl) and chloroquine. All three drugs are believed to affect the lysosome function by decreasing acidification of lysosomes and late endosomes. Despite the common outcome, which is the accumulation of undigested proteins in lysosomes, the treatment with these agents may affect differently the vesicular transport in cells and therefore it is important to compare the data obtained with different lysomorphotropic agents (Negroiu et al., 2005) . In particular, monensin by inhibiting the vacuole ATPase proton pump may also block endocytosis at different steps of endosome maturation and affect the biosynthetic pathway. The other agents act more generally by increasing intracellular pH. First, we analysed E-cadherin redistribution by confocal microscopy in the cells treated with different inhibitors. In control monolayers, monensin treatment for 17 h caused the accumulation of granular intracellular E-cadherin, with no or minor effects on cell morphology ( Supplementary  Information Figure 4 ). This granular staining could be attributed mainly to vesicles of endocytic pathway, as it is not reduced by co-treatment with agents blocking protein synthesis (Supplementary Information Figure  3b ). Similarly, intense intracellular staining was seen in cells treated with chloroquine (Supplementary Figure 5) . As expected, this staining was stronger in TGFb plus 4HT-treated cells, suggesting that more E-cadherin is directed to lysosomes in cells undergoing EMT. In addition, treatment with monensin interfered with the loss of E-cadherin from the cell membrane and EMT-associated morphological changes like cell elongation. This was less evident in case of chloroquine (Supplementary Figure 5) . Moreover, some E-cadherin-positive vesicular structures stained positive for LAMP-1, a known marker for lysosomes and late endosomes, and for Cathepsin D, a more specific marker for lysosomes (Figure 6a ). Similar observations were made in parallel experiments performed with chloroquine (Supplementary Figure 5) . These data were corroborated by Western blot analysis of E-cadherin-soluble and -insoluble fractions from cells treated with lysomorphotropic agents (Figure  6b and c) . We observed an increase in detergent-soluble fraction of E-cadherin in cells treated with lysosome inhibitors, which was more pronounced in epithelial cells stimulated to undergo EMT by TGFb plus 4HT. Furthermore, the detergent-insoluble fraction, which is normally strongly reduced at this time point in EMT (48 h) remained high in the presence of monensin or ammonium chloride (Figure 6b ). In contrast, the treatment with chloroquine for 4 h did not prevent efficiently the loss of E-cadherin from the insoluble fraction (cell membrane) upon induction of EMT. After prolonged incubation times with chloroquine like 18 h, we found even a decrease in membrane-bound E-cadherin. Importantly, however, chloroquine induced the accumulation of partially degraded forms of E-cadherin around 100 kDa and reduction in a 30 kDa degradation product (see arrows, Figure 6c ). In both cases, the effect was proportional to the time of treatment. These data suggest that in response to factors inducing EMT such as TGFb and 4HT, a portion of E-cadherin is finally directed to lysosomes, but differences in responses to monensin and chloroquine may implicate that a partial cleavage of E-cadherin occurs before reaching the lysosomes in the 'monensinsensitive', but 'chloroquine-resistant' vesicles.
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If E-cadherin is more efficiently degraded via endocytic pathway in cells stimulated to undergo EMT by TGFb plus 4HT, the half-life of E-cadherin should be shorter under the latter conditions. We addressed this by performing a pulse-chase experiment, on the confluent epithelial cells labelled with [ S]methionine. After this time, the radioactive medium was rinsed out and cells were incubated or not in the presence of 20 mM monensin. As seen in Figure 6d and e, the half life of E-cadherin is clearly reduced in cells induced to undergo EMT compared to control epithelial monolayer (8 vs 18 h). S]methionine for 2 h. After this time, 20 mM monensin was added to the induced cells. Cell lysates were prepared at the time points indicated processed for E-cadherin IP. Equal aliquots of IP were run on the gel that was processed for autoradiography. (e) Densitometric analysis of the E-cadherin signal of the experiment from (d). Optical density of E-cadherin band at 120 kDa were normalized to E-cadherin at the 0 h time point as in (e).
In addition, the decrease of E-cadherin half-life was observable also immediately after EMT induction (Supplementary Figure 6) . Importantly, E-cadherin stability, reduced by the synergistic action exerted by TGFb and 4HT, was fully restored by monensin treatment (Figure 6d and e) .
In conclusion, results presented in this section suggest that E-cadherin degradation in initial phases of EMT occurs in lysosomes. These data, however, do not exclude that some protease cleavage may occur before reaching the lysosomes in 'monensin-and ammonium chloride'-sensitive compartments.
Cooperation of Raf and TGFb pathway in induction of Hakai and E-cadherin ubiquitination
Endocytosis of E-cadherin has been recently linked to tyrosine phosphorylation and monoubiquitination of E-cadherin by E3-type ubiquitin ligase referred to as Hakai (Fujita et al., 2002) . We therefore analysed if any of the factors contributing to EMT and endocytosis of E-cadherin in RafER-EpH4 cells might affect Hakai gene transcription. PolyA RNA was isolated from cells grown on filters, and stimulated for 48 h before lysis. As shown in Figure 7a , Northern blot analysis indicated that Hakai mRNA is present at low levels in control Figure 7 Induction of Hakai by TGFb and phosphorylation of E-cadherin in response to Raf activation correlate with synergistic induction of E-cadherin ubiquitination. (a) Northern blot analysis of Hakai mRNA induction by 4HT, TGFb or both. Cells were seeded on Transwell filters, and 2 days later, they were stimulated with 0.1 mM 4HT, 5 ng/ml TGFb or both for 48 h, and lysates were processed for polyA mRNA extraction. mRNA isolated from 250 mg total RNA and was loaded onto each lane and Northern blot analysis was performed with mouse Hakai probe. A probe detecting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (b) Densitometric analysis of Hakai induction. The mean values of optical density normalized to GAPDH intensity from three independent experiments are expressed in arbitrary units. Error bars represent standard deviation. (c) Raf/MAPK hyperactivation leads to tyrosine phosphorylation of E-cadherin. Confluent monolayers of serum-starved EpH4 RafER cells (24 h starvation) were treated with 1 mM 4HT or 5 ng/ml TGFb for 24 h. Cells were then lysed in RIPA/CSK (1:1) buffer and E-cadherin was immunoprecipitated (see Materials and methods). IP and total lysates (T) were run on SDS-PAGE and blotted first with antiphosphotyrosine antibodies (upper panel), followed by anti-E-cadherin antibodies (second panel). Note that the increase of tyrosine phosphorylation could be observed both in E-cadherin IP as in total lysates from cells treated with 4HT. (d) Western blot analysis of ubiquitination of E-cadherin immunoprecipitated from cell lysates prepared as described in Materials and methods of RafER cells stimulated 48 h with 5 ng/ml TGFb and/or 0.1 mM 4HT. Position of the strongest band just above 120 kDa suggests that E-cadherin is ubiquitinated mainly by a single ubiquitin molecule. This experiment was performed four times and gave qualitatively similar results. (e) Densitometric analysis of ubiquitin signal above 120 kDa from (c). Integrated optical density normalized to the E-cadherin signal (low exposure) is expressed in arbitrary units.
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E Janda et al cells and was not induced by 4HT. In contrast, TGFb clearly induced Hakai transcription, both alone as well as in combination with 4HT ( Figure 7a) . Quantification of the relative induction of Hakai mRNA by densitometry suggests that Hakai is regulated by TGFb, independently of Raf hyperactivation (Figure 7b ). Next, we wanted to verify if E-cadherin tyrosine phosphorylation played a role in our system. Immunoprecipitation (IP) of E-cadherin and blotting with a mixture of anti-phosphotyrosine antibodies confirmed this hypothesis. We observed an increase in phosphotyrosine signal both in total lysates and in immunoprecipitated E-cadherin at 120 kDa, both from 4HT and double-treated cells (Figure 7c ). This indicates that the serine-threonine kinase Raf hyperactivation is mainly responsible for this effect and indirectly may mediate the tyrosine phosphorylation of E-cadherin. Finally, we tested if E-cadherin tyrosine phosphorylation and Hakai induction correlate with E-cadherin ubiquitination. Cells were stimulated in standard conditions and lysed 48 h later in 1%SDS lysis buffer to disrupt possible E-cadherin complexes with other proteins. Next E-cadherin was immunoprecipitated (see Materials and methods) and subjected to Western blotting with antiubiquitin antibodies. Double-treated cells showed the strongest level of ubiquitination, higher than the partial ubiquitination induced by 4HT and TGFb alone (Figure 7d ). The differences in the ubiquitin signal were not owing to the amount of loaded E-cadherin (Figure 7d , middle panel) and could not be attributed to an ubiquitinated form of b-catenin, as in these conditions no b-catenin was co-immunoprecipitated with E-cadherin (Figure 7d, lowest panel) . Densitometric analysis of the signal, normalized to the amount of loaded E-cadherin, suggested that contribution of Raf/MAPK pathway and TGFb to ubiquitination of E-cadherin is synergistic (Figure 7e ).
Discussion
In this paper, we described an inducible cellular system (RafER-EpH4) to perform kinetic analysis of EMT, central for both development and tumor progression (Grunert et al., 2003) . In this system, MAPK hyperactivation can be induced at will by 4HT activation of the fusion protein dRafER, its strength depending on 4HT concentration. 4HT-activated RafER alters epithelial polarity in a dosage-dependent manner, causing a partial loss of epithelial polarity at 4HT concentrations that do not interfere with cell proliferation. In contrast, combination of RafER activation at this level with TGFb signaling causes EMT as defined by a fibroblastoid phenotype and progressive loss of E-cadherin expression, as well as upregulation of other TGFbtarget genes involved in EMT and invasion (e.g. Tenascin C, PAI-1). The main finding of this paper is that E-cadherin downregulation during early phases of EMT occurs mainly through post-translational mechanisms such as ubiquitination, endocytosis and lysosomal degradation. The transcriptional downregulation of E-cadherin (as evident in many human tumors) is a late process during EMT.
For a number of genes, the cooperation of TGFb and Raf in the induction of EMT clearly occurs at the level of early and rapid transcriptional regulation (e.g. PAI-1, Tenascin C, the E-cadherin-repressor slug and the cell cycle regulator cdk-1; this paper, R Foisner and H Beng, unpublished). Most likely, this involves synergistic action of ERK signaling and Smad-regulated transcription factor complexes regulating the expression of such genes. Such a synergism has been observed in developmental processes analogous to EMT, for instance, mid gut induction in Drosophila (Szuts et al., 1998) . One known mechanism explaining the convergence between Ras and TGFb signaling on many promoters might be a direct physical interaction of both Smad3 and c-jun and c-fos transcription factors, which are targets of ERK kinases (Zhang et al., 1998; Liberati et al., 1999) .
Importantly, transcriptional repression of E-cadherin does not take place at early stages of EMT. In our RafER-EpH4 cell model, TGFb, 4HT or both agents do not affect E-cadherin mRNA levels at least until day 5 of EMT induction, when we observe a partial reduction in the message. Instead, downregulation of E-cadherin protein is visible already after 24-48 h. Therefore, posttranslational regulation of E-cadherin precedes for 2-3 days its transcriptional repression. Similar results were obtained in two other cellular models of EMT (EpRas cells and FosER cells). At first sight, this is surprising since in several other models of tumor progression based on established carcinoma cell lines, E-cadherin repression occurred mainly at the transcriptional level (Cano et al., 2000; Guaita et al., 2002) . Similarly, repression of E-cadherin mRNA occurs during EMT-like processes in development, such as differentiation of the dorsal ectoderm into the neural tube (Nose and Takeichi, 1986) . The latter cell/embryonic systems, however, mainly address gene expression changes that occur after completion of EMT, rather than looking at intermediate stages. They, in fact, correspond well to the above cellular models, as in all of them E-cadherin mRNA is fully repressed in cells having completed the EMT process (e.g. mesenchymal EpRas cells isolated from mouse tumors (Oft et al., 1996) and FosER cells cultivated after estradiol-induced EMT for 21 days (Reichmann et al., 1992) . In conclusion, alternative, post-transcriptional mechanisms must exist to account for E-cadherin protein reduction at the onset of EMT, preceding transcriptional repression of E-cadherin mRNA at late stages or upon completion of EMT.
Here, we propose that E-cadherin downregulation at the onset of EMT is mediated mainly by endocytosis, favoring lysosomal degradation instead of recycling. In accordance with Le et al. (1999) , a low level of cytosolicand detergent-soluble E-cadherin is already present in control cells forming a confluent monolayer. However, as shown in this study the clathrin-dependent endocytosis is strongly augmented in depolarized epithelial cells undergoing EMT. Very good colocalization of E-cadherin with clathrin in vesicles retained by temperature block and the increase in the membrane E-cadherin upon chloropromazine and high sucrose treatment suggests that the preferred endocytic pathway of E-cadherin is clathrin dependent. We cannot exclude a possible involvement of a caveolin pathway in E-cadherin internalization. Nystatin that blocks the caveolin-dependent endocytosis reduces the number of round E-cadherin vesicles and some caveolin-positive E-cadherin vesicles could occasionally be detected. E-cadherin may well be endocytosed by both pathways under certain conditions, similarly to EGF receptors as reported recently (Sigismund et al., 2005) . Further studies would be required to validate the relationship between clathrin-and caveole-mediated endocytosis of adherens junction proteins in polarized/ depolarized epithelial cells vs cells undergoing EMT. However, this was not in the intention of authors in this report, focused mainly on cooperation of TGFb and Raf/MAPK pathway in the downregulation of E-cadherin.
Both TGFb signaling and sustained activation of Raf/ MAPK alone seem to alter the stability of adherens-and tight junctions and this leads to partial loss of epithelial polarity. This may involve different primary mechanisms as cells treated with 4HT and TGFb alone display quite distinct phenotypes. It is also conceivable that liberation of E-cadherin during disruption of protein complexes forming adhesive junctions could indirectly enhance endocytosis and lysosomal degradation of E-cadherin. However, in several other systems, where endocytosis of E-cadherin was described, no downregulation of its levels was reported or documented (Kamei et al., 1999; Ivanov et al., 2004) , suggesting that specific Raf-and TGFb-dependent mechanisms must regulate this process. In this report, we begin to identify these mechanisms. First of all, we show that TGFb and MAPK pathway cooperate to induce E-cadherin localization in structures positive for lysosome markers (Cathepsin D and LAMP-1). E-cadherin vesicles positive for LAMP-1 or Cathepsin D could not be detected in control monolayers, suggesting that cooperation of both pathways favors lysosomal targeting of E-cadherin. Moreover, we found that inhibitors of lysosomal proteolysis like monensin and chloroquine prevented E-cadherin degradation to different extent. Monensin and ammonium chloride, but not chloroquine, blocked the loss of E-cadherin from the plasma membrane in cells co-stimulated with TGFb plus tamoxifen, suggesting that partial E-cadherin fragmentation may occur before it reaches the lysosomes. In support of this hypothesis, we found that colocalization of E-cadherin with lysosome markers could be detected only with antibody (Ab) directed to the intracellular portion of E-cadherin, but not with Ab directed to extracellular portion of E-cadherin, suggesting that E-cadherin containing the epitope recognized by Zymed Ab is not transported to lysosomes (E Janda, unpublished observation) . In this report, we do not investigate possible steps of E-cadherin degradation in detail, but we follow-up with the study of upstream mechanisms. We show that Raf and TGFb cooperate synergistically in the induction of E-cadherin monoubiquitination. This effect may be well explained by TGFb-dependent transcriptional induction of E3 ubiquitin ligase Hakai-and RafER-dependent tyrosine phosphorylation of E-cadherin documented here. Although serinethreonine kinase Raf cannot directly phosphorylate E-cadherin on tyrosines, a general increase in tyrosine phosphorylation upon Raf hyperactivation in our system suggests that Raf/MAPK pathway triggers a multitude of tyrosine kinases, which may directly phosphorylate E-cadherin, such as Src. In fact, E-cadherin phosphorylation by Src was reported to be a prerequisite for its monoubiquitination by Hakai (Fujita et al., 2002) . It is not clear if in our system phosphorylation and monoubiquitination are sufficient signals to target the E-cadherin to late endosomes and lysosomal degradation.
The recent model proposed for MDCK cells, suggested that monoubiquitination and phosphorylation together are sufficient signals to target the marked E-cadherin to lysosomal degradation (Palacios et al., 2005) . In our system, the increase in Hakai expression owing to TGFb and increase in phosphorylation owing to sustained activity of Raf/MAPK pathway may explain how these two pathways cooperate to reduce the E-cadherin levels in the EMT process. However, as we do observe detectable levels of E-cadherin monoubiquitination in cells that do not eliminate E-cadherin (i.e. untreated or treated with 4HT or TGFb) and therefore do not undergo EMT, it would suggest that ubiquitin tagging is not sufficient for efficient E-cadherin degradation in our system. Therefore, additional mechanisms must exist by which Raf/MAPK and TGFb pathway cooperate to favor the lysosomal degradation and/or proteolytic cleavage of E-cadherin, before the transcriptional repression takes over. First of all, TGFb and Raf/MAPK hyperactivation are known to modulate a whole program of genes, some of them maybe directly involved in the regulation of endocytosis and vesicular trafficking like RhoB, Rab5EP, RAN and others (Zavadil et al., 2001) , some others are known contribute to ECM remodeling and adhesion molecules proteolysis (Schulze et al., 2001) . Events like induction of proteases specifically targeting E-cadherin such as calpain (Rios-Doria et al., 2003) in the cell membrane or in lysosomes may well contribute to the process described here.
Another finding of this work should gain attention. Lysosome inhibitors used in non-toxic concentrations for non-proliferating cells were able to block EMT. This opens the possibility to consider the development of highly specific agents targeting lysosomal degradation of junctional proteins as means to prevent metastasis.
Materials and methods
Cell culture
The origin and culture conditions for EpH4 mouse mammary epithelial cells and their Has-Ras-transformed derivative EpRas have been described earlier (Reichmann et al., 1992) .
Endocytosis and lysosomal degradation of E-cadherin E Janda et al EpH4-RafER clones were generated by retroviral gene transfer. The retroviral constructs hb-RafER-EGFP-pBabepuro and an control vector hb-pBabe-EGFP-puro (Lehmann et al., 2000) were used to transfect the Phoenixt packaging cell line (grown in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal calf serum (FCS) and 2 mM glutamine, after recent hygromycin B/diptheria toxin selection for optimal virus production). After 2-3 days, virus supernatants from the transfected packaging cells were used to infect EpH4, which were then selected with 5 mg/ml puromycin (3-4 days). Infected mass cultures were FACS sorted for GFP-positive cells, then used to isolate GFP-positive clones by seeding at low density, marking single adherent cells 8 h later, expansion for 7-9 days and isolation of colonies using trypsin-soaked filter paper circles. EpH4 RafER, FosER and EpRas cells were routinely cultured in standard DMEM with 5% (EpRas) or 10% FCS and 2 mM glutamine on plastic dishes. Before each experiment, 2-4 Â 10 5 cells were seeded on semipermeable polycarbonate filters (Transwellt; Corning Costar, NY, Cat. no. 3450) and cultured for indicated time periods before the start of the experiment, but not shorter than 24 h. Treatments with factors and 4HT were started at indicated time points before the end of experiment when cells were lysed. This experimental scheme was adopted to compare points at similar cell density at the end of experiment.
Reagents and antibodies
Rat anti-mouse-E-cadherin Ab against the extracellular portion of E-cadherin (Zymed, San Francisco, CA, USA, cat. no. 13-1900) was used for immunofluorescence (unless stated otherwise); mouse monoclonal Ab (BD Pharmingen, San Diego, CA, USA, cat. no. 610181) 1:4000 was used to detect E-cadherin by Western blot and in some cases for immunofluorescence. Anti-phosphotyrosine Ab cocktail PY-Plus (Zymed, cat. no. 13-6600), anti-phospho-ERK Ab (Cell Signaling Tech., Beverly, MA, USA) anti-ERK2 Ab, antiubiquitin (BabCo, Richmond, CA, USA, cat. no. MMS-258) were used in Western blotting. The following Abs were used for immunofluorescence: anti-clathrin, anti-Rab5, anti-caveolin (Transduction Laboratories) and monoclonal anti-mouse vimentin, Vim-13.4 (Sigma-Aldrich, St. Louis, MO, USA, cat. no. V-2258). Goat anti-cathepsin D (sc-6494) and LAMP-1 (sc-8098) and antibodies used for normalization such as antiactin (sc-1516) and anti a-tubulin (sc-5286) were from Santa Cruz Biotech., Santa Cruz, CA, USA.
4-HT was kept as ethanol solution at À201C. TGFb was from Biosource Int., Camarillo, CA, USA; aliquots were shock frozen if they had to be re-used and kept at À701C. Monensin, okadaic acid and proteasome inhibitor I (cat. no. 539160) were from Calbiochem, La Jolla, CA, USA, whereas chloropromazine (cat. no. 46125), nystatin (cat. no. N-6261) and cyclohexamide (C1988) from Sigma-Aldrich, St. Louis, MO, USA.
Preparation and fractionation of cell lysates, Western blot analysis To analyse total cellular proteins by Western blotting, cells from one Transwell filter were lysed in 400 ml SDS lysis buffer (10 mM Tris:HCl, pH 7.5, 150 mM NaCl, 0.5 mM ethylenediaminetetraacetic acid, 1 mM ethyleneglycol tetraacetate, 1% SDS) plus a cocktail of protease inhibitors (Calbiochem). The protein concentration was analysed by D c protein Reagent Assay (Bio-Rad Lab., Hercules, CA, USA). For optimal detection of E-cadherin, only 3 mg of total protein per gel lane were loaded and were analysed by 6 or 8% SDS-PAGE and immunoblotted as described previously (Janda et al., 2002b) .
To separate the membrane-bound from soluble intracellular E-cadherin, cells were lysed in CSK buffer (Zhu et al., 2001) containing 0.5% Triton-X100 or 0.1% Triton-X100 as indicated, incubated 15 min on ice passed through a 27 G needle four times, and then centrifuged 20 min at 24 000 g at 41C. The pellet was solubilized in 5 Â sample buffer (5% SDS) and incubated 20 min at 901C. The amount of supernatant corresponding to 5 Â 10 4 cells and pellet fractions from 10 5 cells were loaded on the same gel and analysed by 8% SDS-PAGE and immunoblotted as described.
Immunoprecipitation
For phosphotyrosine detection 300 000 cells were seeded onto filters and grown for 5 days up to the density 1.8-2 ml/filter, serum starved for 24 h and stimulated for 24 h. Cells were lysed in denaturating radioimmunoprecipitation assay (RIPA) (1% NP40, 0.5% deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM Tris, pH 7.5): CSK buffer (see above) (1:1) with protease inhibitors cocktail (Calbiochem) and 10 mM Na 3 VO 4 , 5 mM phenylmethylsulfonyl fluoride (PMSF), 100 mM NaF, 2 mM iodoacetic acid, 5 mM okadaic acid, incubated 20 min on ice, passed 4 Â through a 27 G needle and centrifuged 10 min at 14 000 r.p.m. for clearing. Cleared lysates (200 mg) were used for IP with 2 mg of rat anti-E-cadherin Ab (Zymed), after 1 h pre-incubation with 30 ml of protein A/G beads (Amersham Biosciences, Uppsala, Sweden). Bead-Ab samples were washed three times with 500 ml lysis buffer (RIPA:CSK, 1:1) For ubiquitination detection, 5 Â 10 5 cells were seeded onto Transwell filters and stimulated as indicated in the figures 24 h later. After 48 h, stimulation cells were lysed as described in Fujita et al. (2002) and 500 mg total lysates were pre-cleared with 25 ml of protein A/G beads (Pharmacia) and subjected to IP with 2.5 mg mouse anti-E-cadherin (Transduction Laboratories) and 5 mg of Rat Ab Decma-1 (Sigma, cat. no. U 3254) for 2 h. IP samples were separated on 6% gel and transferred to polyvinylidine difluoride membrane. After electroblotting, the membrane was pre-incubated with denaturing buffer (6 M guanidine-HCl, 20 mM Tris-HCl, pH 7.5, 5 mM b-mercaptoethanol, 1 mM PMSF) for 30 min at 41C, washed extensively in phosphate-buffered saline (PBS) and blocked with 5% bovine serum albumin in Tris-buffered saline Tween-20 (TrisHCl) for 6 h at room temperature (RT). Next, the membrane was incubated at 41C with the anti-ubiquitin Ab diluted 1:1000 in blocking solution.
Immunofluorescence and confocal microscopy analysis Filters were rinsed twice with Hank's solution plus glucose or PBS, fixed in paraformaldehyde (PFA) 4% for 10 min at RT, dried, washed with PBS and blocked for 1 h in 0.2% gelatin in PBS containing non-immune goat or bovine immunoglobulins (IgGs) (20 mg/ml) and 0.05% Tween-20. Filters were then incubated first with Ab (diluted in blocking solution lacking non-immune IgGs) for 1 h, washed five times in PBS containing 0.05% Tween, treated with similarly prepared dilutions of secondary antibodies for 30 min and washed again as above (first wash containing 2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI); 1 mg/ml stock, final dilution 1:10 000). Alexat-conjugated secondary antibodies against rabbit or mouse IgG (Molecular Probes Inc., Eugene, OR, USA) were diluted 1:1000, whereas Cy3-conjugated goat antirabbit or anti-rat or IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) were diluted 1:300. Confocal analysis was performed using a Leica-TCS-NT confocal microscope. For vertical section images (XZ analysis), 40-50 horizontal scans using a Â 63 or Â 100 (section step 0.22 mm) oil-immersion objective were recorded for each channel, whereas XY images were obtained from a single horizontal scan from representative fields.
Metabolic labeling
In experiments analysing E-cadherin stability in the presence of monensin, cells were cultured on small filters 3 days, induced with 4HT and TGFb for 48h, and incubated with methionine free-medium for 2 h and for additional 1 h 50 min with [
35 S]methionine (Amersham Biosciences, Piscataway, NJ, USA) at a concentration of 1 mCi/ml. After careful washes with PBS and three times with serum-free DMEM, cells were incubated in regular DMEM 10% FCS containing 4HT and TGFb and 20 mM monensin where required. After times indicated cells were lysed in RIPA:CSK buffer (1:1) supplemented with protease inhibitors. Total lysates (400 mg) were used for 14 h IP with 8 mg of the rat anti-E-cadherin Ab Decma-1. After four washes in RIPA buffer, IP samples were analysed by NuPage (Invitrogen, Carlsbad, CA, USA) gel electrophoresis in 3-[N-morpholino]propane sulfonic acid buffer, followed by fixation and drying of the gel as recommended by the manufacturer's protocol. Densitometric analysis was performed with QuantityOne software (Biorad).
Northern blotting
Total RNA was isolated from cells seeded on transwell filters (six filters for each experimental point) by Trizol (Invitrogen) extraction following the manufacturer's instructions. PolyA RNA was isolated from 250 mg of total RNA using Oligotex Mini Kit (Qiagen, Valencia, CA, USA, cat. no. 70022) and was loaded onto each lane. Northern blotting was performed as described earlier (Janda et al., 2002b) .
